One important metric to look for in a stock is an 80 or higher Relative Strength Rating. Tempus AI just hit that mark, with a jump from 67 to 89 Thursday.
Looking For The Best Stocks To Buy And Watch? Start Here
IBD's unique RS Rating tracks technical performance by showing how a stock's price action over the last 52 weeks measures up against that of other stocks on the major indexes.
Decades of market research shows that the stocks that go on to make the biggest gains tend to have an 80 or higher RS Rating as they begin their biggest climbs.
Tempus AI is not currently offering a proper buying opportunity. See if the stock goes on to form a chart pattern that could kick off a new price move.
The company reported 0% EPS growth in its most recent report, while sales growth came in at 36%.
The company earns the No. 7 rank among its peers in the Medical-Research Equipment/Services industry group. Veracyte, Natera and Tempus AI are among the top 5 highly rated stocks within the group.
This article was created automatically with Stats Perform's Wordsmith software using data and article templates supplied by Investor's Business Daily. An IBD journalist may have edited the article.
RELATED:
Stocks With Rising Relative Strength Ratings
Why Should You Use IBD's Relative Strength Rating?
How Relative Strength Line Can Help You Judge A Stock
Ready To Grow Your Investing Skills? Join An IBD Meetup Group!
